Skip to main content

2017 Press Releases

Keyword Search
 
2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010
DateTitle 
06/14/17Bard Declares Quarterly Dividend
MURRAY HILL, N.J.--(BUSINESS WIRE)--Jun. 14, 2017-- The Board of Directors of C. R. Bard, Inc. (NYSE:BCR) today declared a regular quarterly dividend of 26 cents per share on Bard's common stock. The current indicated annual dividend rate is $1.04 per share. The dividend is payable on August 4, 2017 to shareholders of record at the close of business on July 24, 2017. C. R. Bard, Inc. (www.crbard.com), headquartered in Murray Hill, NJ, is a... 
Printer Friendly Version
06/09/17BD and Bard Receive Second Requests from FTC under HSR Act
Companies continue to expect the transaction to close in the fall of 2017 FRANKLIN LAKES, N.J., and MURRAY HILL, N.J., June 9, 2017 /PRNewswire/ -- BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, and C. R. Bard, Inc. (NYSE: BCR), a medical technology leader in the fields of vascular, urology, oncology and surgical specialty products, announced today that the two companies have each received a request for additional information ("second request") from... 
Printer Friendly Version
04/23/17Bard Announces First Quarter Results
MURRAY HILL, N.J.--(BUSINESS WIRE)--Apr. 23, 2017-- C. R. Bard, Inc. (NYSE:BCR) today reported 2017 first quarter financial results, prior to their previously communicated schedule. The company has included supplemental financial data on its website related to this earnings release. Given the transaction announced with Becton, Dickinson and Company (NYSE:BDX) today, and the associated conference call tomorrow, the company is cancelling the previously sch... 
Printer Friendly Version
04/23/17BD To Acquire Bard For $24 Billion
Will Create Highly Differentiated Medical Technology Company Focused on Delivering Innovative Healthcare Solutions to Improve Clinical and Economic Outcomes Will Build on BD's Leadership Position in Medication Management and Infection Prevention; Will Increase Opportunities in Innovative Fast-Growing Clinical Areas Financially Compelling Transaction; Immediately Accretive and Expected to Generate High Single-Digit Accretion to Adjusted EPS in Fiscal Year 2019 Tom Polen Named BD President ... 
Printer Friendly Version
04/19/17Bard Declares Quarterly Dividend
MURRAY HILL, N.J.--(BUSINESS WIRE)--Apr. 19, 2017-- The Board of Directors of C. R. Bard, Inc. (NYSE-BCR) today declared a regular quarterly dividend of 26 cents per share on Bard's common stock. The current indicated annual dividend rate is $1.04 per share. The dividend is payable on May 12, 2017 to shareholders of record at the close of business on May 1, 2017. C. R. Bard, Inc. (www.crbard.com), headquartered in Murray Hill, NJ, is a lea... 
Printer Friendly Version
03/07/17Bard to Present at Barclays Global Healthcare Conference
MURRAY HILL, N.J.--(BUSINESS WIRE)--Mar. 7, 2017-- C. R. Bard, Inc. (NYSE: BCR) today announced that it will present at the Barclays Global Healthcare Conference in Miami, Florida on March 14, 2017. Timothy M. Ring, chairman and chief executive officer, will discuss the Company in a presentation scheduled to begin at 3:50 PM Eastern Daylight Time. A live webcast of Bard's presentation will be accessible to all investors through Bard’s webs... 
Printer Friendly Version
02/27/17Bard to Present at Cowen and Company Healthcare Conference
MURRAY HILL, N.J.--(BUSINESS WIRE)--Feb. 27, 2017-- C. R. Bard, Inc. (NYSE:BCR) today announced that it will present at the Cowen and Company Healthcare Conference in Boston, Massachusetts on March 6, 2017. Christopher S. Holland, senior vice president and chief financial officer, will discuss the Company in a presentation scheduled to begin at 3:20 PM Eastern Standard Time. A live webcast of Bard's presentation will be accessible to all i... 
Printer Friendly Version
01/26/17Bard Announces Fourth Quarter Results
MURRAY HILL, N.J.--(BUSINESS WIRE)--Jan. 26, 2017-- C. R. Bard, Inc. (NYSE:BCR) today reported 2016 fourth quarter financial results. Fourth quarter 2016 net sales were $967.1 million, an increase of 11 percent on an as-reported basis over the prior-year period. Excluding the impact of foreign exchange, fourth quarter 2016 net sales increased 12 percent over the prior-year period. For the fourth quarter 2016, net sales in the U.S. were $655.0 mil... 
Printer Friendly Version
01/04/17Bard to Host Earnings Conference Call on January 26, 2017
MURRAY HILL, N.J.--(BUSINESS WIRE)--Jan. 4, 2017-- C. R. Bard, Inc. (NYSE:BCR) today announced that it will host a conference call on Thursday, January 26, 2017 at 5:00 PM EST, to discuss the company’s fourth quarter and full year 2016 operating results, and to provide financial guidance for 2017. Bard is scheduled to issue an earnings press release after the market closes on January 26, 2017. A live audio webcast of Bard's investor conference wi... 
Printer Friendly Version
01/03/17Bard to Present at J. P. Morgan Healthcare Conference
MURRAY HILL, N.J.--(BUSINESS WIRE)--Jan. 3, 2017-- C. R. Bard, Inc. (NYSE: BCR) today announced that it will present at the J.P. Morgan Healthcare Conference in San Francisco, California on January 10, 2017. Timothy M. Ring, chairman and chief executive officer, will discuss the Company in a presentation scheduled to begin at 9:30 AM Pacific Standard Time. A live webcast of Bard's presentation will be accessible to all investors through Ba... 
Printer Friendly Version
Print Page Print Page | E-mail Page E-mail Page | RSS Feeds RSS Feeds | E-mail Alerts E-mail Alerts | IR Contacts IR Contacts | Financial Tear Sheet Tear Sheet